| Supports a healthy respiratory
system by providing breathing enhancement
 AsmaSpray
(with Coleus Forshkolii and Tylphora Asthmatica Spray) supports a healthy
respiratory system. Asthma cases have increased by 400% since 1980, to
approximately 3 million. Asthma is characterised by a hyper-response of
the trachea and bronchi, which results in a a narrowing of the airways
in the lung.
Mast cells are intimately involved in releasing chemical mediators that
enhance or inhibit the asthmatic attack. Mast cells have receptors for
cAMP and cGMP. cAMP inhibits the release of histamine, cAMP is released
under the stimulation of the enzyme adenylate cyclase. The receptor that
activates this enzyme is the beta-receptor. Drugs that are beta-receptor
antagonists enhance cAMP release, and inhibit histamine release that eases
the asthmatic attack. The relative ratios of cAMP and cGMP have direct
consequence on whether an asthma attack will occur.
The problem is with drugs is their side effects and no one wants to keep
pumping steroids into their body if they can help it.
The ability of C.Forshkolii to activate intracellular cAMP is what makes
it so valuable as a therapeutic component. Forshkolii stimulates the enzyme
adenylate cyclase to release cAMP. As these levels rise it inhibits the
release of chemical mediators. This relaxes bronchial smooth muscle and
helps prevents bronchi-spasm. These products are not offered as a treatment
or a cure for any medical conditions, but only as a nutritional support. |
